Hazards of THA Revision (95 % CI) | P-value* | Hazards of THA Revision (95 % CI) | P-value* | |
2-year data | 5-year data | |||
N = 3151 with 88 events | N = 2461 with 71 events | |||
Harris Hip Score categories | ||||
≤ 55 vs. 81–100 | 3.90 (2.67,5.69) | < 0.001 | 2.48 (1.56,3.95) | < 0.001 |
56–63 vs. 81–100 | 2.24 (1.45,3.46) | < 0.001 | 2.04 (1.25,3.32) | < 0.001 |
64–71 vs. 81–100 | 2.36 (1.60,3.49) | < 0.001 | 2.78 (1.72,4.48) | < 0.001 |
72–80 vs. 81–100 | 2.18 (1.61,2.94) | < 0.001 | 2.43 (1.70,3.460 | < 0.001 |
Harris Hip Score clinical categories | ||||
< 70 vs. 90–100 | 3.40 (2.59,4.45) | < 0.001 | 2.65 (1.92,3.66) | < 0.001 |
70–79 vs. 90–100 | 2.66 (1.92,3.68) | < 0.001 | 2.88 (1.96,4.25) | < 0.001 |
80–89 vs. 90–100 | 2.02 (159,2.57) | < 0.001 | 1.64 (1.21,2.24) | < 0.001 |
N = 1011 with 13 events | N = 583 with 5 events | |||
Improvements in Harris Hip Score | ||||
≤ 0 vs. 51–75 | 2.48 (1.00,6.14) | 0.05 | 2.30 (0.46,11.61) | 0.31 |
1–20 vs. 51–75 | 0.99 (0.38,2.57) | 0.98 | 1.97 (0.63,6.15) | 0.24 |
21–50 vs. 51–75 | 0.68 (0.40,1.15) | 0.15 | 0.92 (0.42,2.02) | 0.84 |